DPIIT recognised startup Government of India
Startup India
Rynish Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.17 Lakh
▼ 98% YoY
Net profit · FY 2025
₹36,056
Net margin 30.9%
EBITDA · FY 2025
₹61,700
EBITDA margin 52.9%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹15 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Rynish Pharmaceuticals Private Limited
Data last updated:
Rynish Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 September 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2021PTC367756. Its GSTIN is 27AALCR2908N1ZU (Maharashtra).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Raina Dilip Desai and Nishit Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 701 7th Floor Leela Business Park Opp Leela Hotel Ak Road Andheri (East), Mumbai, Maharashtra, India – 400059.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.17 Lakh, a decline of 98% compared to the previous year. For the same year it recorded a net profit of ₹36,056 (net margin 30.9%) and EBITDA of ₹61,700 (EBITDA margin 52.9%).
Rynish Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0201535). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rynish.com.
Company details
CIN U24290MH2021PTC367756
Registration Number 367756
Incorporation Date 20 September 2021
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-MH-19-0201535
Recognitions & Rankings of Rynish Pharmaceuticals
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-19-0201535
Contact details
Rynish Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is rynish.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address701 7th Floor Leela Business Park Opp Leela Hotel Ak Road Andheri (East), Mumbai, Maharashtra, India – 400059
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Rynish Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Rynish Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Rynish Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Rynish Pharmaceuticals Private Limited, buy the company report.
Financials of Rynish Pharmaceuticals Private Limited
FY 2025 filings availableRynish Pharmaceuticals Private Limited reported revenue of ₹1.17 Lakh (down 98% YoY) for FY 2025.
Revenue · FY 2025
₹1.17 Lakh ▼ 98%
Net profit · FY 2025
₹36,056 margin 30.9%
EBITDA · FY 2025
₹61,700 margin 52.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 98%
EBITDA CAGR growth
1 year
▼ 53%
3 years · compounded
▲ 32%
Revenue fell 98% in the latest year. EBITDA fell 53% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹61,700 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹36,056 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 52.9% | |||
| Net Profit Margin | 30.9% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Rynish Pharmaceuticals Private Limited, buy the company report.
Board of directors of Rynish Pharmaceuticals Private Limited
Rynish Pharmaceuticals has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raina Dilip Desai Also directs: Rraynex Pharmaceuticals Private Limited, DHC Global Technologies Private Limited, DBD Investments Limited and 4 more | Director | 20 Sep 2021 | 5 Years 1 Months | Current |
| Nishit Gupta Also directs: Rraynex Pharmaceuticals Private Limited | Director | 20 Sep 2021 | 5 Years 1 Months | Current |
| Minal Dilip Desai Also directs: Minal D. Desai Advisory LLP, Rraynex Pharmaceuticals Private Limited, DHC Global Technologies Private Limited and 5 more | Director | 14 Mar 2022 | 4 Years 7 Months | Current |
Auditor
Rynish Pharmaceuticals Private Limited is audited by Niranjan Ghosh & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Niranjan Ghosh & Associates | FY 2023 | 332753E |
Shareholding
The shareholding of Rynish Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Rynish Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Rynish Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rynish Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Rynish Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 07, 2024.
Active EPFO establishments
1
GST
Rynish Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AALCR2908N1ZU | Maharashtra | Active | 10 Feb 2022 |
To see the full GST registrations and return filing status of Rynish Pharmaceuticals Private Limited, buy the company report.
Recent activity
Rynish Pharmaceuticals Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Minal Dilip Desai was appointed as Director on 14 Mar 2022.
AGM
Rynish Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Rynish Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Appointed
Minal Dilip Desai was appointed as Director.
Appointed
Nishit Gupta was appointed as Director.
Appointed
Raina Dilip Desai was appointed as Director.
Incorporation
20 Sep 2021
Rynish Pharmaceuticals Private Limited was registered on 20 Sep 2021 with Roc Mumbai I & aged 5 years 1 month as per MCA records.
Frequently asked questions
Rynish Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 September 2021 (5+ years old) and is registered under CIN U24290MH2021PTC367756.
Rynish Pharmaceuticals has 3 current directors:
- Raina Dilip Desai - Director
- Nishit Gupta - Director
- Minal Dilip Desai - Director
The latest financial statements of Rynish Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Rynish Pharmaceuticals is 27AALCR2908N1ZU, registered in Maharashtra.
The CIN (Corporate Identification Number) of Rynish Pharmaceuticals is U24290MH2021PTC367756. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rynish Pharmaceuticals was incorporated on 20 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
Minal Dilip Desai was appointed as Director on 14 Mar 2022. Nishit Gupta was appointed as Director on 20 Sep 2021. Raina Dilip Desai was appointed as Director on 20 Sep 2021.
Yes, Rynish Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Rynish Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0201535).
Rynish Pharmaceuticals can be reached through the website rynish.com. Its registered office is in Mumbai, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages